From Yahoo Finance: 2025-04-28 06:37:00

Amgen is investing $900m in expanding its manufacturing facility in Ohio, bringing total investments in the state to $1.4bn and creating 750 jobs. The move aims to enhance manufacturing offerings in the US. Amgen has invested almost $5bn in the US since 2017, contributing $12bn to the economy.

The Ohio expansion is part of Amgen’s global biomanufacturing network, aligning with its focus on establishing biologics manufacturing capabilities worldwide. CEO Robert Bradway emphasized the commitment to expanding US manufacturing for global patient access. Amgen recently inaugurated a new drug substance facility in North Carolina with a $1bn expansion announcement.

The investments in Ohio and North Carolina demonstrate Amgen’s dedication to expanding manufacturing capabilities and ensuring global access to innovative medicines. The company’s strategic investments in the US align with its commitment to enhancing biologics manufacturing globally.



Read more at Yahoo Finance: Amgen to invest $900m in Ohio manufacturing facility